Stockreport

Roivant Announces Genevant Sciences' and Arbutus Biopharma's $2.25 Billion Global Settlement With Moderna [Yahoo! Finance]

Roivant Sciences Ltd.  (ROIV) 
PDF Roivant Sciences Moderna to pay Genevant and Arbutus $950 million upfront and an additional $1.3 billion contingent upon a favorable resolution of Moderna's Section 1 [Read more]